CHICAGO (Reuters) – Britain’s AstraZeneca Plc on Tuesday said data from early-stage trials of its experimental cancer drug, MEDI4736, are encouraging and support moving the immunotherapy into pivotal-stage testing. The findings were part of a series of presentations by…
Source:Cancer drug data supports advanced trials: AstraZeneca
Tuesday, June 3, 2014
Cancer drug data supports advanced trials: AstraZeneca
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment